Patents by Inventor Steven E. Bushnell

Steven E. Bushnell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040265808
    Abstract: The present invention relates to methods of diagnosis, therapy, and screening of new therapeutic compounds in the field of osteogenesis, based on the differential expression observed for the genes of the invention, represented by SEQ ID No 1 to SEQ ID No 150, or SEQ ID No 151, 152 or 153, or SEQ ID No 154 to SEQ ID No 196, or SEQ ID No 197 to SEQ ID No 210, or SEQ ID No 211 to SEQ ID No 229, or SEQ ID No 230 to SEQ ID No 234, or SEQ ID No 235 to SEQ ID No 245.
    Type: Application
    Filed: May 3, 2004
    Publication date: December 30, 2004
    Inventors: Teresa Garcia, Sergio Roman Roman, Roland Baron, Katherine Call, Joachim Theilhaber, Timothy Connolly, Amanda Jackson, Steven E Bushnell, Georges Rawadi
  • Publication number: 20020144298
    Abstract: This invention relates to novel human genes, to proteins expressed by the genes, and to variants of the proteins. The invention also relates to diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly colon cancer cell lines and/or tissue.
    Type: Application
    Filed: June 11, 2001
    Publication date: October 3, 2002
    Inventors: Wilson O. Endege, Kathleen E. Steinmann, Jon H. Astle, Christopher C. Burgess, Steven E. Bushnell, Eddie Carroll, Theodore J. Catino, Adnan Derti, Donna M. Ford, Marcia E. Lewis, John E. Mohahan, Robert Schlegel
  • Patent number: 6262333
    Abstract: This invention relates to novel human genes, to proteins expressed by the genes, and to variants of the proteins. The invention also relates to diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs. and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly colon cancer cell lines and/or tissue.
    Type: Grant
    Filed: June 8, 1999
    Date of Patent: July 17, 2001
    Assignee: Bayer Corporation
    Inventors: Wilson O. Endege, Kathleen E. Steinmann, Jon H. Astle, Christopher C. Burgess, Steven E. Bushnell, Eddie Carroll, III, Theodore J. Catino, Adnan Derti, Donna M. Ford, Marcia E. Lewis, John E. Monahan, Robert Schlegel
  • Patent number: 5888835
    Abstract: Method and apparatus for enabling resuspension wash and magnetic localization of sample components bound to particles with magnetic properties in reaction vessels during separation and wash for enhanced chemiluminescent signal generation in biomedical assays. The assays involve moving reaction vessels past magnetic arrays that partially localized the particles prior to passing a gap where washing occurs, with or without resuspension, after separating out the unbound components and liquid. The band of particles is further localized by a focusing magnet at the end of the array prior to dosing the vessel with acid for chemiluminescent purposes. A block of soft magnetic material is employed in place of a magnet in the gap to minimize magnetic strength at the gap. Trimmed magnets adjacent the gap cause left, then right, particle shifting that localizes the magnetizable particles. The gap enables improved resuspension by wash, whereas the localized particles enable more efficient resuspension by reagent.
    Type: Grant
    Filed: May 10, 1996
    Date of Patent: March 30, 1999
    Assignee: Chiron Diagnostics Corporation
    Inventors: Steven E. Bushnell, Tina K. Garyantes, Michael L. Malek, Howard J. Kirchick